Skip to content

Supplier News

Merck Rx label redesign gets FDA OK

The Food and Drug Administration has approved redesigned drug container labels from Merck. The FDA said late last week that the revamped labels feature a new standardized format to improve readability and provide better information on product and strength differentiation.

Breckenridge unveils new generics

Breckenridge Pharmaceutical Inc. has received Food and Drug Administration approval for letrozole 2.5 mg tablets and estradiol/norethindrone acetate 0.5mg/0.1mg tablets.

Tropicana expands Trop50 juice line

Tropicana Products Inc. has added lemonade and raspberry lemonade flavors to its Trop50 fruit juice line, which has 50% less sugar and calories plus no artificial sweeteners.

Watson to launch Lybrel generic

Watson Pharmaceuticals Inc. is set to ship levonorgestrel and ethinyl estradiol birth control tablets. The company said this week that its subsidiary, Watson Laboratories Inc., received approval from the Food and Drug Administration for levonorgestrel and ethinyl estradiol tablets 0.09 mg/0.02 mg.

Pfizer holding first virtual clinical trial

Pfizer Inc. is conducting what it said is the first-ever randomized clinical trial under an investigational new drug (IND) application that manages study participation entirely using electronic tools and enables patients to participate in the trial regardless of geography.

P&G makes exec changes in beauty, grooming

Procter & Gamble Co. has announced the several organizational changes in its global beauty care and grooming businesses. P&G said Tuesday that Charles (Chip) Bergh is retiring from the company after 28 years "to pursue his aspiration to be CEO of a major company.

ECRM names new president

Mitchell Bowlus, chief financial officer at ECRM, has been appointed president at retail and consumer product manufacturer solution provider.

Teva begins shipping generic of Aricept

Teva Pharmaceutical Industries Ltd. has rolled out donepezil hydrochloride tablets, a medication for Alzheimer’s disease. The company said Wednesday that it has received Food and Drug Administration approval to market a generic version of Eisai’s Aricept Tablets in strengths of 5 mg and 10 mg.